904-P: Glycemic Improvement in Patients with Type 2 Diabetes under Treatment with a Fixed-Dose Combination Glimepiride/Vildagliptin/Metformin with Failure to Previous Dual Therapy

• Published in: Diabetes (New York, N.Y.) Vol. 73; no. Supplement_1; p. 1
• Main Authors: RIOS-BRITO, KEVIN F., RODRIGUEZ-ROCANDIO, KARLA E., SANDER-PADILLA, JOSE G., LUGO-SÁNCHEZ, LAURA A., ROMERO, YULIA, ARGUEDAS, MARÍA M., MORA, JULIO C., RODRIGUEZ-VAZQUEZ, ILEANA C., FLORES-HUANOSTA, DIANA, GONZALEZ-CANUDAS, JORGE
• Format: Journal Article
• Language: English
• Published: New York American Diabetes Association 14.06.2024
• Subjects: Antidiabetics; Diabetes; Diabetes mellitus (non-insulin dependent); Hemoglobin; Hypoglycemia; Metformin; Sulfonylurea

Introduction & Objective: Failure to type 2 diabetes (T2D) treatment leads to complications. Combination therapies with different mechanisms of action are often required to achieve glycemic goals. This study aimed to evaluate the efficacy and safety of glimepiride/vildagliptin/metformin in patie...